Related Experiment Video
Updated: Apr 9, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
General population screening for type 1 diabetes: has its time come?
Richard A Insel1, Jessica L Dunne, Anette-G Ziegler
1aJDRF, New York, USA bInstitute of Diabetes Research, Helmholtz Zentrum München, Munich cForschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München, Neuherberg, Germany.
General childhood screening can identify children at risk for type 1 diabetes (T1D) by detecting islet autoantibodies. This approach enables early intervention and prevention strategies for T1D.
Area of Science:
- Pediatrics
- Immunology
- Endocrinology
Background:
- Type 1 diabetes (T1D) is an autoimmune disease.
- Early detection of T1D risk is crucial for intervention.
Purpose of the Study:
- To explore the potential of general childhood population-based screening for T1D risk.
- To assess methods for identifying individuals at high risk for developing symptomatic T1D.
Main Methods:
- Screening for multiple islet autoantibodies and glucose intolerance (dysglycemia).
- Investigating human leukocyte antigen (HLA) risk genotypes in neonates.
- Utilizing routine well-child visits for autoantibody detection.
- The Fr1da study in Bavaria (launched 2015) as a pilot.
Main Results:
- The presence of multiple islet autoantibodies and dysglycemia can identify early stages of T1D.
- Population-based autoantibody screening at well-child visits can detect a significant proportion of at-risk children.
- Screening strategies can estimate T1D progression risk.
Conclusions:
- General childhood screening for T1D risk identifies at-risk populations.
- This enables participation in natural history studies to understand pathogenesis.
- Facilitates intervention trials for disease prevention and public health strategies for childhood-onset T1D.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

